Restrictive Drug Coverage Policies can Induce Substantial Drug Exposure Misclassification in Pharmacoepidemiologic Studies

被引:9
作者
Gamble, John-Michael [1 ,2 ]
McAlister, Finlay A. [2 ,3 ,4 ]
Johnson, Jeffrey A. [1 ,2 ]
Eurich, Dean T. [1 ,2 ]
机构
[1] Univ Alberta, Li Ka Shing Ctr Hlth Res Innovat 2 040, Sch Publ Hlth, Edmonton, AB T6G 2E1, Canada
[2] Univ Alberta, ACHORD, Edmonton, AB T6G 2E1, Canada
[3] Mazankowski Alberta Heart Inst, Edmonton, AB, Canada
[4] Univ Alberta, Dept Med, Div Gen Internal Med, Edmonton, AB T6G 2E1, Canada
基金
加拿大健康研究院;
关键词
formularies; misclassification; pharmaceutical policy; pharmacoepidemiology; CLAIMS DATABASES; UNITED-STATES; CANADA; EPIDEMIOLOGY; MEDICATION; ACCURACY; PHARMACY; THERAPY;
D O I
10.1016/j.clinthera.2012.04.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Drugs reimbursed through a single-party payer such as health maintenance organizations or provincial governments are generally captured in administrative data if they have full-benefit status on that payer's formulary. However, drugs subject to restrictive drug coverage policies are often not fully captured if patients receive these drugs through mechanisms other than the single-payer formulary. Objective: The goal of this study was to estimate the association between restrictive drug coverage and drug exposure misclassification across the Canadian provinces of Manitoba and Saskatchewan, which provide universal coverage for formulary-approved drugs to all citizens regardless of age or socioeconomic status. Methods: Monthly dispensations were compared for 75 drugs between 2005 and 2008 from Canada's National Prescription Drug Utilization System database, which captures provincial drug formulary claims only, versus the IMS Brogan CompuScript Database, which captures all drug dispensations irrespective of formulary status. The association between restrictive drug coverage and drug exposure misclassification was measured using generalized estimating equations and multivariable adjustment. Results: On average, 84% of monthly retail drug dispensations were captured by provincial claims data: 100% of monthly dispensations were captured for drugs with full-benefit status but only 61% of dispensations for drugs with restrictive drug coverage (adjusted risk ratio = 0.65 [95% confidence interval, 0.56-0.75]). The direction and magnitude of the potential misclassification bias between full-benefit and restricted policy drugs were consistent across all drug classes examined: acid-reducing drugs (97% vs 66%), analgesics (89% vs 64%), central nervous system drugs (103% vs 61%), cardiovascular drugs (100% vs 57%), diabetes drugs (98% vs 61%), osteoporcsis drugs (96% vs 57%), and respiratory drugs (112% vs 60%). Conclusions: Drugs subject to restrictive coverage policies are substantially under-captured in administrative databases, leading to potential drug exposure misclassification in pharmacoepidemiologic studies relying on administrative databases. Pharmacoepidemiologic studies should clearly describe whether evaluated drugs are available as full benefits or subject to restrictive coverage policies and the potential impact on their results. (Clin Ther. 2012;34:1379-1386) (C) 2012 Elsevier HS Journals, Inc. All rights reserved.
引用
收藏
页码:1379 / 1386
页数:8
相关论文
共 31 条
[1]  
Canadian Institute for Health Information, ANT US SEN AN BRIEF
[2]  
Canadian Institute for Health Information, 2000, HORM REPL THER AN FO
[3]  
Canadian Institute for Health Information, 2000, DRUG CLAIMS SEN AN F
[4]  
Canadian Institute for Health Information, BISPH OST AN BRIEF
[5]   Thiazolidinediones and Fractures in Men and Women [J].
Dormuth, Colin R. ;
Carney, Greg ;
Carleton, Bruce ;
Bassett, Ken ;
Wright, Jarnes M. .
ARCHIVES OF INTERNAL MEDICINE, 2009, 169 (15) :1395-1402
[6]  
Downey W, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P295
[7]   Making Observational Studies Count Shaping the Future of Comparative Effectiveness Research [J].
Dreyer, Nancy A. .
EPIDEMIOLOGY, 2011, 22 (03) :295-297
[8]   Quantifying the Impact of Drug Exposure Misclassification due to Restrictive Drug Coverage in Administrative Databases: A Simulation Cohort Study [J].
Gamble, John-Michael ;
McAlister, Finlay A. ;
Johnson, Jeffrey A. ;
Eurich, Dean T. .
VALUE IN HEALTH, 2012, 15 (01) :191-197
[9]   Prior-authorization programs for controlling drug spending [J].
Hamel, MB ;
Epstein, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (21) :2156-2158
[10]   Statistical analysis of correlated data using generalized estimating equations: An orientation [J].
Hanley, JA ;
Negassa, A ;
Edwardes, MDD ;
Forrester, JE .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 157 (04) :364-375